Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $76.29M (100.0% shares, 0.0% debt)

Holdings (18)

— VERONA PHARMA PLC 12.8%

Value $9.792M Shares 487,631 Est. Cost $20.08 Unrealized —

XENE XENON PHARMACEUTICALS INC 12.5%

Value $9.555M Shares 266,961 Est. Cost $36.94 Unrealized 0.0%

— BELLUS HEALTH INC NEW 10.7%

Value $8.149M Shares 1,131,827 Est. Cost $7.20 Unrealized —

CYTK CYTOKINETICS INC 10.3%

Value $7.861M Shares 223,382 Est. Cost $40.80 Unrealized 0.0%

MDGL MADRIGAL PHARMACEUTICALS INC 9.4%

Value $7.174M Shares 29,614 Est. Cost $272.48 Unrealized 0.0%

— IVERIC BIO INC 8.1%

Value $6.212M Shares 255,310 Est. Cost $24.33 Unrealized —

— MERUS NV 6.7%

Value $5.078M Shares 275,970 Est. Cost $18.40 Unrealized —

— MERSANA THERAPEUTICS INC 6.4%

Value $4.896M Shares 1,191,271 Est. Cost $6.56 Unrealized —

— JASPER THERAPEUTICS INC 6.0%

Value $4.556M Shares 2,517,232 Est. Cost $1.81 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 3.8%

Value $2.871M Shares 20,830 Est. Cost $129.72 Unrealized 0.0%

— CTI BIOPHARMA CORP 3.0%

Value $2.31M Shares 550,000 Est. Cost $4.20 Unrealized —

— MEDAVAIL HOLDINGS INC 2.2%

Value $1.689M Shares 5,894,897 Est. Cost $8.23 Unrealized —

— MDXHEALTH SA 2.1%

Value $1.62M Shares 500,000 Est. Cost $3.24 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 2.0%

Value $1.558M Shares 72,850 Est. Cost $16.81 Unrealized 0.0%

RPID RAPID MICRO BIOSYSTEMS INC 1.2%

Value $917K Shares 699,664 Est. Cost $15.69 Unrealized -91.7%

— ESSA PHARMA INC 0.9%

Value $703K Shares 236,583 Est. Cost $2.52 Unrealized —

— KINNATE BIOPHARMA INC 0.9%

Value $684K Shares 109,393 Est. Cost $6.25 Unrealized —

SYRS SYROS PHARMACEUTICALS INC 0.9%

Value $665K Shares 249,126 Est. Cost $8.12 Unrealized -52.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	VERONA PHARMA PLC	487,631	$9.792M	12.8%	$20.08	—	SPONSORED ADS	925050106
XENE	XENON PHARMACEUTICALS INC	266,961	$9.555M	12.5%	$36.94	0.0%	COM	98420N105
—	BELLUS HEALTH INC NEW	1,131,827	$8.149M	10.7%	$7.20	—	COM NEW	07987C204
CYTK	CYTOKINETICS INC	223,382	$7.861M	10.3%	$40.80	0.0%	COM NEW	23282W605
MDGL	MADRIGAL PHARMACEUTICALS INC	29,614	$7.174M	9.4%	$272.48	0.0%	COM	558868105
—	IVERIC BIO INC	255,310	$6.212M	8.1%	$24.33	—	COM	46583P102
—	MERUS NV	275,970	$5.078M	6.7%	$18.40	—	COM	N5749R100
—	MERSANA THERAPEUTICS INC	1,191,271	$4.896M	6.4%	$6.56	—	COM	59045L106
—	JASPER THERAPEUTICS INC	2,517,232	$4.556M	6.0%	$1.81	—	COM	471871103
SRPT	SAREPTA THERAPEUTICS INC	20,830	$2.871M	3.8%	$129.72	0.0%	COM	803607100
—	CTI BIOPHARMA CORP	550,000	$2.31M	3.0%	$4.20	—	COM	12648L601
—	MEDAVAIL HOLDINGS INC	5,894,897	$1.689M	2.2%	$8.23	—	COM	58406B103
—	MDXHEALTH SA	500,000	$1.62M	2.1%	$3.24	—	SPONSORED ADS	58286E102
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	72,850	$1.558M	2.0%	$16.81	0.0%	CLASS A ORD	61559X104
RPID	RAPID MICRO BIOSYSTEMS INC	699,664	$917K	1.2%	$15.69	-91.7%	CLASS A COM	75340L104
—	ESSA PHARMA INC	236,583	$703K	0.9%	$2.52	—	COM NEW	29668H708
—	KINNATE BIOPHARMA INC	109,393	$684K	0.9%	$6.25	—	COM	49705R105
SYRS	SYROS PHARMACEUTICALS INC	249,126	$665K	0.9%	$8.12	-52.3%	COM NEW	87184Q206